CCND2 is a prognostic biomarker and correlates with immune infiltration in lung adenocarcinoma
Authors:
Open Access
- 1 March 2024
- journal article
- research article
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 13 (3) , 1241-1251
Abstract
Background: CCND2 expression influences the growth and proliferation of cancer cells and plays a crucial role in immune response of tumor. However, few studies focused on the correlation between CCND2 and lung adenocarcinoma (LUAD) in terms of prognosis and tumor immune infiltration. Methods: Original LUAD case data were screened from The Cancer Genome Atlas (TCGA) database. Using R software, we analyzed differently expressed CCND2 between LUAD and adjacent normal tissues. Kaplan-Meier analysis was conducted to determine the relationship between CCND2 expression and the overall survival of LUAD patients, and Cox regression analysis was performed to identify the independently prognostic risk factors for LUAD. Using TIMER (Tumor Immune Estimation Resource) and CIBERSORTx (Cell-type Identification by Estimating Relative Subsets of known RNA Transcripts) databases, the connection between CCND2 expression and LUAD immune infiltration was investigated. Results: The level of CCND2 was significantly lower in LUAD than in adjacent normal tissues [adjusted P+ T cells (r=0.287, P=7.88e−11), CD4+ T cells (r=0.301, P=8.14e−12), macrophages (r=0.128, P=4.57e−03), neutrophils (r=0.373, P=1.07e−17), and myeloid dendritic cells (r=0.284, P=1.43e−10). The levels of B cells and macrophages had significantly association with the overall survival of LUAD patients. CIBERSORTx showed that the proportions of naive B cells, resting dendritic cells, and macrophages M1 were higher in the low CCND2 expression group (P+ memory cells were lower (PConclusions: CCND2 can be exploited as a novel prognostic biomarker involved in immune infiltration of LUAD, hence providing new preventative and therapeutic options for LUAD.Keywords
This publication has 30 references indexed in Scilit:
- Molecular Profiling Reveals a Tumor-Promoting Phenotype of Monocytes and Macrophages in Human Cancer ProgressionImmunity, 2014
- D-type Cyclins are important downstream effectors of cytokine signaling that regulate the proliferation of normal and neoplastic mammary epithelial cellsMolecular and Cellular Endocrinology, 2014
- Microenvironmental regulation of tumor progression and metastasisNature Medicine, 2013
- MicroRNA 17–92 expressed by a transposone‐based vector changes expression level of cell‐cycle‐related genesCell Biology International, 2012
- DNA methylation profile during multistage progression of pulmonary adenocarcinomasVirchows Archiv, 2011
- Promoter methylation status of the Cyclin D2 gene is associated with poor prognosis in human epithelial ovarian cancerCancer Science, 2007
- Regulation and Function of Cyclin D2 in B Lymphocyte SubsetsThe Journal of Immunology, 2004
- Cyclin D-dependent kinases, INK4 inhibitors and cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2002
- The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapiesThe Journal of Pathology, 2002
- Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survivalBritish Journal of Cancer, 1998